- Home
- WHG vs SEER Comparison
WHG vs SEER Comparison
Compare WHG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHG
- SEER
- Stock Information
- Founded
- WHG 1983
- SEER 2017
- Country
- WHG United States
- SEER United States
- Employees
- WHG N/A
- SEER N/A
- Industry
- WHG Investment Managers
- SEER Medicinal Chemicals and Botanical Products
- Sector
- WHG Finance
- SEER Health Care
- Exchange
- WHG Nasdaq
- SEER Nasdaq
- Market Cap
- WHG 146.3M
- SEER 121.8M
- IPO Year
- WHG 2002
- SEER 2020
- Fundamental
- Price
- WHG $14.56
- SEER $2.14
- Analyst Decision
- WHG
- SEER Hold
- Analyst Count
- WHG 0
- SEER 1
- Target Price
- WHG N/A
- SEER $3.00
- AVG Volume (30 Days)
- WHG 16.5K
- SEER 459.8K
- Earning Date
- WHG 04-30-2025
- SEER 05-13-2025
- Dividend Yield
- WHG 4.06%
- SEER N/A
- EPS Growth
- WHG N/A
- SEER N/A
- EPS
- WHG 0.04
- SEER N/A
- Revenue
- WHG $95,241,000.00
- SEER $15,309,000.00
- Revenue This Year
- WHG N/A
- SEER $26.65
- Revenue Next Year
- WHG N/A
- SEER $29.42
- P/E Ratio
- WHG $309.53
- SEER N/A
- Revenue Growth
- WHG 6.08
- SEER N/A
- 52 Week Low
- WHG $11.11
- SEER $1.56
- 52 Week High
- WHG $18.03
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- WHG 38.75
- SEER 59.41
- Support Level
- WHG $14.78
- SEER $2.04
- Resistance Level
- WHG $15.46
- SEER $2.07
- Average True Range (ATR)
- WHG 0.43
- SEER 0.13
- MACD
- WHG -0.02
- SEER -0.00
- Stochastic Oscillator
- WHG 4.72
- SEER 60.61
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.